FOLH1 and prostate carcinoma: We retrospectively analyzed data from prostate cancer patients, includingPSMA PET/CT-derived features (SUVmax, SUVmean, PSMA-TVp, TL-PSMAp) and clinical-pathological variables (age, tPSA, Gleason score).